Bronwen Christine Evans Net Worth

What's Bronwen Evans's mailing address?

Bronwen's mailing address filed with the SEC is 111 PETER STREET, SUITE 300, , TORONTO, A6, M5V 2G9.

Insiders trading at Cronos Inc

Over the last 4 years, insiders at Cronos Inc have traded over $30,495,757 worth of Cronos Inc stock and bought 1,848,320 units worth $4,899,192 . The most active insiders traders include Michael Ryan Gorenstein, Jason Marc Adler e Jeffrey David Jacobson. On average, Cronos Inc executives and independent directors trade stock every 15 days with the average trade being worth of $528,456. The most recent stock trade was executed by James Andrew Iii Mc Ginness on 29 August 2024, trading 14,618 units of CRON stock currently worth $31,867.

What does Cronos Inc do?

cronos group is a globally diversified and vertically integrated cannabis company with a presence across four continents. the company operates two wholly-owned canadian licensed producers regulated under health canada’s access to cannabis for medical purposes regulations: peace naturals project inc. (ontario), which was the first non-incumbent medical cannabis license granted by health canada, and original bc ltd. (british columbia), which is based in the okanagan valley. the company has multiple international production and distribution platforms: cronos israel and cronos australia. through an exclusive distribution agreement, cronos also has access to over 12,000 pharmacies in germany as the company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.

Cronos Inc executives and stock owners

Cronos Inc executives and other stock owners filed with the SEC include:

• Anna Shlimak,
  Sr. VP of Corp. Affairs
• Dr. Todd K. Abraham,
  Chief Innovation Officer
• Michael Ryan Gorenstein J.D.,
  Exec. Chairman
• Michael Ryan Gorenstein,
  Exec. Chairman
• Xiuming Shum,
  Exec. VP of Legal and Regulatory Affairs & Corp. Sec.
• Kurt Thomas Schmidt B.Sc., M.B.A.,
  Pres & CEO
• Jerry Filomena Barbato,
  Chief Financial Officer
• Arye Weigensberg,
  Interim Head of R&D
• Summer Frein,
  Gen. Mang. of USA
• Robert L. Madore,
  Chief Financial Officer
• Jeffrey David Jacobson,
  Gen. Mang. of Canada & Europe
• Shannon Buggy,
  Sr. VP & Global Head of People
• Shayne J. Laidlaw,
  Director of Investor Relations & Strategy
• Carlos Cortez,
  VP, Controller & Principal Accounting Officer
• James Andrew Iii Mc Ginness,
  VP, Controller
• John Griese,
  See Remarks
• Group, Inc.Altria Summit Ll...,
  
• Terrence Gregory Joseph Doucet,
  See Remarks
• Bronwen Christine Evans,
  Director
• Jason Marc Adler,
  Director
• James Daniel Rudyk,
  Director
• Kurt Schmidt,
  See Remarks
• Jeffrey David Jacobson,
  Chief Growth Officer
• Todd Kevin Abraham,
  Chief Innovation Officer
• Anna Shlimak,
  See Remarks
• Puneet Mathur,
  Vice President & Controller
• Xiu Ming Shum,
  See Remarks
• Summer Frein,
  General Manager, USA
• Shannon Buggy,
  SVP, Global Head of People
• Kendrick Foster Jr Ashton,
  Director
• Carlos S. Cortez,
  VP, Controller
• Robert L Madore,
  Chief Financial Officer
• Ran Gorelik,
  
• Michael Ryan Gorenstein,
  See remarks below
• Arye Weigensberg,
  See Remarks
• James Holm,
  Chief Financial Officer
• Murray R Garnick,
  Director
• Adam Wagner,
  SVP, Head of Cronos Israel